NeuroTalk Support Groups

NeuroTalk Support Groups (https://www.neurotalk.org/)
-   Multiple Sclerosis (https://www.neurotalk.org/multiple-sclerosis/)
-   -   New MS Drug / Dirucotide? (https://www.neurotalk.org/multiple-sclerosis/52769-ms-drug-dirucotide.html)

dmplaura 08-26-2008 01:03 AM

weeble, good luck with your decision hun. Much respect! :hug:

SandyC 08-26-2008 11:10 AM

I am going to ask Jim's spinal cord doctor to look and see if Jim ever had the HLA test. We don't remember because it's been so long ago, 20 years.

lady_express_44 08-26-2008 11:16 AM

Quote:

Originally Posted by weeble (Post 354921)
Because the Phase II/III study is happening in Canada and Europe for SPMS as well as another study for SPMS in the States. I have been asked by my MS clinic if I would be willing to consider entering this trial. I said yes, but I have a series of tests/ assessments this upcoming month. I'm not really in a position to receive a placebo. If I find out more, I'll let everyone know.

I don't even know if I'm a carrier of the HLA markers required.

I could probably do this trial too, but my neuro has given up on trying to recruit me as a guinea pig. I suppose if I could stay on LDN at the same time (she has always promised I could do that, no matter what trial she's tried to talk me into), then I might consider this particular one.

They like drug virgins, and since I don't intend to take anything else anyway, maybe this would be a good option for me.

Could you please let me know what you find out; where the trial center is, lead researcher in BC, trial criteria, etc. if they give you the documentation on it?

Thanks!

weeble 08-26-2008 11:25 AM

Quote:

Originally Posted by lady_express_44 (Post 355123)
I could probably do this trial too, but my neuro has given up on trying to recruit me as a guinea pig. I suppose if I could stay on LDN at the same time (she has always promised I could do that, no matter what trial she's tried to talk me into), then I might consider this particular one.

They like drug virgins, and since I don't intend to take anything else anyway, maybe this would be a good option for me.

Could you please let me know what you find out; where the trial center is, lead researcher in BC, trial criteria, etc. if they give you the documentation on it?

Thanks!

Will do. Next drug treatment plan will come after my next MRI Wed Sept 3rd.

weeble 08-26-2008 11:28 AM

Quote:

Originally Posted by Erin524 (Post 354493)
I hope it works, because I'm getting so tired of the nightly stab of Copaxone that I've been slacking off a lot the past few weeks.

If all I had to do was go and get an IV two or three times a year, I'd switch to that.

I'd do the IV every day if it would stop my progression right where it is for the rest of my life.

SallyC 08-26-2008 01:54 PM

This really sounds very pomising for all of you/us. Why is it always two to 5 years off.:confused:

I'm too old for trials, but too young to not, still, have hope.:) Bring it on!!!! :cool:

Keep us tuned, Kelly..:hug:

SandyC 08-26-2008 06:27 PM

That's right Sally! Sounds like everyone will possibly benefit from this drug.

dmplaura 08-26-2008 06:29 PM

Quote:

Originally Posted by SallyC (Post 355253)
I'm too old for trials, but too young to not, still, have hope.:) Bring it on!!!! :cool:

Sally, I love this positive attitude!

lady_express_44 09-04-2008 09:36 AM

Multiple Sclerosis drug dirucotide (MBP8298) receives fast track designation from FDA


BioMS Medical Corp. announced that the Food and Drug Administration (FDA) of the United States has granted fast track designation for the Company's lead drug, dirucotide (MBP8298), for the treatment of secondary progressive MS (SPMS). Dirucotide (MBP8298) is currently being evaluated in a U.S. pivotal phase III trial, named MAESTRO-03, at 68 sites with approximately 510 patients.

Fast track designation is an FDA status reserved for products that are intended to treat a serious or life-threatening condition and that demonstrate the potential to address unmet medical needs for that condition. Fast track designation can potentially facilitate development and expedite the review process.

"Our receipt of fast track designation for dirucotide in the U.S. is a significant milestone for both BioMS Medical and the MS community," said Kevin Giese, President and CEO of BioMS Medical. "Based on previous clinical results, we believe dirucotide is well-positioned to become a first-in-class treatment for secondary progressive MS patients, a large patient population with very limited treatment options."

Source: BioMS Medical Corp. (04/09/08)

http://www.msrc.co.uk/index.cfm?fuse...ow&pageid=1308

wkikta 09-04-2008 10:10 AM

The Trials are closed, fully subscribed by patients and Doctors. I believe the Canadian/European trial is finished. I believe Fast Track is what Tysabri got.


All times are GMT -5. The time now is 12:49 AM.

Powered by vBulletin • Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise (Lite) - vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.